A short duration of ischemia (i.e., ischemic pre conditioning) results in significant brain protection to subse quent severe ischemic insult. Because previous studies suggest that tumor necrosis factor-ex (TNF-ex) plays a role in both pro moting ischemic damage and neuroprotection, the present work aimed to evaluate the expression of TNF-ex mRNA in an es tablished model of ischemic preconditioning using a transient 10-minute occlusion of the middle cerebral artery. Because the level of TNF-ex mRNA expression in the brain was too low to be consistently detected by Northern technique, a real-time polymerase chain reaction method was applied to quantitate the absolute copy number of TNF-ex transcript in rat brain after the
Tumor necrosis factor a (TNF-a) is a pleitrophic cy tokine with diverse biologic activities. TNF-a is ex pressed in monocytes/macrophages as well as many other cells including glia and neurons (Akira et al., 1990; Liu et al., 1994; Munozfernandez and Fresno, 1998) . Whereas normal brain tissue has little or no TNF-a ex pression, this cytokine is significantly induced after tran sient or permanent focal cerebral ischemia Wang et al., 1994; Buttini et al., 1996) . In addition, TNF-a receptors are also present in the brain and may mediate neuronal and glial activation, proliferation, dif ferentiation, and survival (Munozfernandez and Fresno, preconditioning procedure. TNF-ex mRNA was induced in the ipsilateral cortex as early as 1 hour (27 ± I copies of mRNA per microgram of tissue compared to II ± 3 copies in sham operated samples) after preconditioning, reached a peak level at 6 hours (49 ± 10 copies of transcript, n = 4, P < 0.01), and persisted up to 2 days. These data not only demonstrate the utility of real-time polymerase chain reaction for sensitive and accurate measurement of mRNA expression in normal and in jured tissues but also suggest a potential role of TNF-ex in the phenomenon of ischemic preconditioning. Key Words: TNF ex-Ischemic tolerance-Ischemic preconditioning-Focal stroke-TaqMan-Polymerase chain reaction. 1998). Furthermore, the expression of TNFR2 was dem onstrated to be upregulated during cerebral infection (Lucas et al., 1997) .
Although the precise role of TNF-a in brain function and especially in stroke is not fully understood, it has been suggested that TNF-a expression in brain ischemia is detrimental to neurons because the administration of anti-TNF-a antibodies or TNF receptor linked to poly ethylene glycol (TNFbp, which binds and inhibits TNF a) significantly reduced focal cerebral ischemic injury (Dawson et al., 1996; Barone et al., 1997; Nawashiro et al., 1997a) . In addition, in vivo administration of TNF-a into brain parenchyma produced significant inflamma tory reaction in brain capillaries including peri capillary edema and significant leukocyte accumulation (Feuer stein et al., 1994; Liu et al., 1994) . TNF-a administration into the cerebroventricular space before ischemia aug ments the extent of tissue damage and neurologic deficits . These results are in agreement with early studies that suggested TNF-a might play a crucial role in tissue injury during disease processes when it is released from activated lymphocytes, macrophages of peripheral origin, and/or astrocytes and microglia of the brain parenchyma (Martin et aI., 1995; Probert et aI., 1995) .
On the other hand, there is increasing evidence to sug gest that TNF-a may be involved in neuroprotection (Barger et aI., 1995) . For example, TNF receptor knock out mice developed larger lesions after middle cerebral artery occlusion (MCAO) than nontransgenic controls (Bruce et aI., 1996) . Furthermore, mice treated with TNF-a are resistant to focal cerebral ischemia injury (Nawashiro et aI., 1997b) . A similar neuroprotective function (Ohtsuki et aI., 1996) has been demonstrated for another inflammatory cytokine, interleukin-ll3, that was induced after ischemic injury and ischemic tolerance (Minami et aI., 1992; Rothwell and Strijbos, 1995; Ya masaki et aI., 1995; Ohtsuki et ai., 1996; Wang et aI., 1999) .
Taken together, these data suggest that TNF-a may play a role in both ischemic injury and in tolerance in duction. To further explore the role of TNF-a in isch emic tolerance, in the present study we examined TNF-a mRNA expression in a rat model of preconditioning. In this preconditioning model, a transient lO-minute MeAO (used as preconditioning) induced tolerance to subse quent (24 hours later) permanent MeAO, which persists up to 7 days (Barone et ai., 1998) . Under these condi tions, both infarct size and neurologic deficits are re markedly reduced by preconditioning. This precondition ing paradigm is dependent on de novo protein synthesis (Barone et aI., 1998) .
Because our pilot studies revealed that the levels of TNF-a mRNA expression after preconditioning was in consistently detectable by standard Northern hybridiza tion or semiquantitative polymerase chain reaction (PCR) methods (Wang et ai., 1997) , we adopted a novel real-time PCR technique (Gibson et aI., 1996; Heid et ai., 1996) for precise quantitation of TNF-a mRNA expres sion in brain tolerance. This method utilizes a specific fluorogenic probe to hybridize the target sequence that is amplified with a pair of specific PCR primers. The hy bridization signal is detected during peR cycling in pro portion to the accumulation of the PCR products. The end point measurement of fluorescence in each sample provides a homogeneous signal that is specifically asso ciated with the amplified target and quantitatively related to the amount of PCR products. By using a cloned cDNA as a template standard and meanwhile normalizing RNA samples with a housekeeping gene for the real-time peR as described in this report, the absolute copy number of TNF-a transcripts in the cortical samples after precon ditioning was determined. 
MATERIALS AND METHODS

Animals
Focal ischemic preconditioning
Transient MCAO or sham surgery was carried out in spon taneously hypertensive rats, 300 to 350 g, under sodium pen tobarbital anesthesia as described previously (Barone et aI., 1992) . Brieny, after craniotomy using stereotaxic procedures, the dura was opened over the right MCA. The bent tip of a platinum-iridium wire mounted on a micromanipulator was placed under the MCA and used to lift the artery away from the brain surface to temporarily occlude blood now, as verified by monitoring cortical microvascular perfusion (Barone et aI., 1992) . A period of lO minutes of temporary MCAO was uti lized for focal preconditioning because this short ischemic pe riod results in no tissue injury but protects the tissue from late ischemia .
TaqMan real-time reverse transcription-polymerase chain reaction assay
Rat cortex (210 to 260 mg each) was dissected and imme diately frozen in liquid nitrogen and stored at -80°e. Total RNA was prepared by homogenizing the cortical tissues in an acid guanidinium thiocyanate solution and extracted with phe nol and chloroform as previously described (Chomczynski and Sacchi, 1987) . Average RNA yield was about 1 fLg RNA per milligram brain tissue.
The PCR primers and TaqMan probes for TNF-a and rpL32 were designed using a software program from Perkin-Elmer (Foster City, CA, U.S.A.) according to the published rat TNF-a and rpL32 cDNA sequences (S40199; Rajchel et aI., 1988) and summarized in Table 1 . The specificity of PCR primers was tested under normal PCR conditions in a thermocycler (Model 9700, Perkin-Elmer) before TaqMan quantitation. 
The TaqMan probe consists of an oligonucleotide with a 5' -reporter dye 6-carboxyfluorescein (FAM) and a 3' -quencher dye 6-carboxy-tetramethyl-rhodamine (TAMRA). The position of the primers or probes is labeled according to the sequence of rat TNF-a (S40199) and rpL32 (X06483). PCR, poly merase chain reaction; TNF-a tumor necrosis factor alpha.
Reverse transcription (RT) and PCR were carried out using a TaqMan Reverse Transcription Reagents and TaqMan Gold RT-PCR kit (Perkin-Elmer) according to the manufacturer's specification. A two-step RT-PCR was performed. RT reaction used 3 fLg total RNA in a total volume of 40 fLL containing Ix TaqMan ET buffer, 5.5 mmol/L MgClz, 500 fLmol/L of each dNTP, 2.5 fLmol/L oligo d(T)16 primers, 0.4 U/fLL RNase In hibitor and MuItiScribe Reverse Transcriptase. RT reaction was carried out at 25°C for 10 minutes, 48°C for 30 minutes, and 95°C for 5 minutes.
A thermal stable AmpliTaq Gold DNA Polymerase was used for the second strand cDNA synthesis and DNA amplification. Real-time PCR was performed with 4 fLL of RT products (300 ng total RNA), Ix TaqMan buffer A, 5.5 mmollL MgCI20 200 fLmollL dATP/dCTP/dGTP, 400 fLmollL dUTP, 200 nmollL primers (forward and reverse), 100 nmollL TaqMan probe, 0.0 I U/fLL AmpErase and 0.025 U/fLL AmpliTaq Gold DNA Poly merase in a total volume of 50 fLL. PCR was performed at 50°C for 2 minutes (for AmpErase UNG incubation to remove any uracil incorporated into the cDNA), at 95°C for 10 minutes (for AmpliTaq Gold activation) and then run for 40 cycles at 95°C for 15 seconds, and at 60°C for 1 minute on the ABI PRISM 7700 Detection System.
The principle of the real-time detection is based on the fluo rogenic 5 ' nuclease assay as illustrated in Fig. 1 . During the PCR reaction, the AmpliTaq Gold DNA Polymerase cleaves the TaqMan probe at the 5 ' end and separates the reporter dye f rom the quencher dye only if the probe hybridizes to the target.
This cleavage results in the fluorescent signal generated by the cleaved reporter dye and directly monitored by the ABI PRISM 7700 Detection System. The increase in the fluorescence signal is proportional to the amount of the specific PCR product.
Real-time polymerase chain reaction standard curves for TNF -a and rpL32
To determine the absolute copy number of the target tran script, a cloned plasmid DNA for TNF-c:x or rpL32 (Wang et aI., 1 9 94) was used to produce a standard curve. TNF-c:x and rpL32 plasmids contain 710 and 465 base pair (bp) of cDN A insert, respectively, in a pBluescript cloning vector (2958 bp). To determine the copy number of DNA templates, the molecular
A. Polymerization
Forward weights of the plasmids were calculated according to 6.6 x 10 5 per kilobase (kb) average value and then converted into the copy numbers based on the Avogadro's number, i.e., 1 mol = 6.022 x 10 23 molecules. The cloned plasmid DNA was serially diluted (for every 5-fold). Each sample was run in duplicates, and the Il Rn (the ratio for the amount of reporter dye emission to the quenching dye emission) and threshold cycle (Ct) values were averaged from each reaction. Data were analyzed using a Sequence Detector V1.6 program (Perkin-Elmer).
Statistical analysis
Statistical comparisons were made by analysis of variance (ANOVA; Fisher's protected least squares difference) and val ues were considered to be significant when P was <0.05.
RESULTS
Determination of TNF -a and rpL32 standard curves with cloned plasmid DNA using real-time polymerase chain reaction As shown in Fig. 2 , TNF-a and rpL32 plasmids were serially diluted (five-fold dilution ranging from 1.65 to 7.24 log molecules or 16.4 fg to 64 pg for TNF-a tem plate; 3.04 to 7.93 log molecules or 0.409 pg to 0.32 ng for rpL32), and real-time PCR data were plotted using cycle numbers versus Rn (Fig. 2, upper panels) or tem plate copy numbers versus Ct values (Fig. 2, lower pan els). The amplification (as indicated by the Ct value) was in a linear relationship with the initial template concen tration (Fig. 2, lower panels) . All of our testing samples were located within this linear amplification range (Fig.  2, lower panels) . 
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A. Five-fold serial dilutions of the plasmid DNA were used as the templates, ranging from 1.65 to 7.24 log molecules for TNF-a and 3.04 to 7.93 log molecules for rpL32. For each dilution, the �Rn (the ratio for the amount of reporter dye emission to the quenching dye emission) is plotted against the cycle number. Ct is the fractional cycle number at which �Rn crosses some fixed threshhold baseline. The lower panels plot the input DNA templates (log copy numbers) against the Ct values (black dots). Every tested sample (reversibly transcribed from 300 ng of total cellular RNA) is in the linear range of the DNA standard curve (red dots).
TNF-a mRNA in each sample were determined by the Ct value of the TaqMan PCR according to its DNA stan dard. To exclude the inaccuracy of an RNA concentra tion measurement that may result in false information on TNF-a RNA expression, rpL32 was selected as the in ternal control for the normalization of RNA concentra tion because it was demonstrated to be consistently ex pressed in cortical samples after preconditioning (Wang et aI., 1998 ; Fig. 3B ). The levels of rpL32 mRNA ex pression in the cortical samples are approximately 1.01 to 1.53 x 105 copies of transcript per nanogram of total RNA or microgram of tissue (Fig. 3B ). After normaliz ing to the rpL32 transcript, the quantitative data (n = 4) for TNF-a mRNA expression in cortical samples after preconditioning or sham-operated animals are illustrated in Fig. 3A. L o w of mRNA per nanogram of RNA or microgram of tissue) were observed in the contralateral cortex. The levels of TNF-a mRNA expression were rapidly increased (27 ± I copies at I hour) in the ispsilateral cortex after precon ditioning. Significant induction in TNF-a mRNA was observed at 6 hours (49 ± 10 copies of mRNA per mi crogram of tissue, or 4.4-fold increase compared to sham, P < 0.001) and 12 hours after preconditioning (37 ± 9 copies, P < 0.05) (Fig. 3 ).
DISCUSSION
Using a novel, exquisitely sensitive and quantitative real-time PCR technique, the present work describes for the first time a significant induction of TNF-a mRNA expression in brain subjected to a preconditioning pro- jected to sham surgery (6 hours) or after 1, 3, 6, 12 and 24 hours, and 2 and 5 days of preconditioning as described in Materials and
Methods. RT and PCR was carried out using TaqMan quantita tion (illustrated using 1 mg brain tissue or 1 ng RNA for the template). The absolute copy numbers of TNF-rr transcripts (A; n = 4) were determined according to DNA standard and normalized with rpL32. The rpL32 data (n = 4) were determined based on the Ct value and reflect its unnormalized levels in each sample (8).
The results are illustrated as means ± standard deviation. *P < 0.05, ** P < 0.01, compared to sham-operated animals.
cedure. TNF-a. mRNA induction was observed as early as 1 hour and sustained up to 2 days in the ipsilateral cortex after preconditioning. The induced expression of TNF-a. mRNA in ischemic tolerance induced by precon ditioning suggests that this cytokine may contribute to the neuroprotective effect of preconditioning, a proce dure that produces significant ischemic tolerance (Bar one et aI., 1998) . It should also be pointed out that the increased expression of TNF-a. mRNA may not repre sent the level of its increase in protein synthesis, and that even if the increase in the mRNA is translated into pro tein after preconditioning, the physiologic significance of this small-magnitude change of TNF-a. still in our pre conditioning model remains to be evaluated. The benefi cial role of TNF-a. in an lipopolysaccharide-induced tol erance model in rats has been demonstrated by concur rent administration of TNFbp (Tasaki et aI., 1997) . In addition, pretreated mice with TNF-a. induced significant protection against focal cerebral ischemia injury (Na-washiro et aI., 1997b), suggesting a role of TNF-a. in the tolerance to ischemia induced by both lipopolysaccha ride and TNF-a. itself. The molecular mechanisms for the effect of TNF-a. in preconditioning are unknown. As it has been demon strated previously, because the overall effect of TNF-a. expression after brain ischemia appears to be detrimental (Dawson et aI., 1996; Barone et aI., 1997; Nawashiro et aI., 1997a) , the low level of TNF-a. expression after pre conditioning may result in sublethal stress, whereas the sublethal stress may lead to an undefined adaptation that increases resistance to subsequent ischemia. The in volvement of a noxious but sublethal stress in precondi tioning has been demonstrated with various chemical and physical stimuli (Kitagawa et aI., 199 1; Kobayashi et aI., 1995; Chen and Simon, 1997; Riepe et aI., 1997) . It should also be mentioned that a low level of TNF-a. expression after preconditioning may be acting to stimu late brain cells to undergo further adjustments that are the basis for ischemic tolerance.
The real-time PCR represents a novel technology based on the 5' nuclease activity of the Taq DNA poly merase. Early methods of quantitative PCR either rely on a housekeeping gene to serve as an internal control (such as the use of aldolase A and rpL32) for co-amplification (Chelly et aI., 1988; Wang et aI., 1997) or use of the same PCR primers and templates (with a small insertion or deletion in the templates) (Wang et aI., 1989; Gilliland et aI., 1990) . All these methods have disadvantages for pro viding either semi-or inaccurate quantitation because of the involvement of amplification efficiency. The critical difference between the real-time PCR and the previous methods is the use of the threshold cycle numbers as a measure of the initial concentration of the target nucleic acid (Gibson et aI., 1996; Heid et aI., 1996) . Thus, the effect of amplification efficiency differences is minimal as long as the target templates are in the linear range of PCR amplification. This advantage makes TaqMan PCR sensitive, accurate, and able to produce high throughput for quantitation of mRNA, especially in its application to detect those of a low number of expressed genes or when limited amount of tissue is available.
In conclusion, our present data illustrate the applica tion of a sensitive and quantitative real-time PCR method for the accurate measurement of TNF-a. mRNA expres sion in the brain and demonstrate for the first time the presence of TNF-a. mRNA (though at very low levels) in normal tissue and its induction at a state of tolerance to ischemic insult. The induced expression of TNF-a. by preconditioning suggests that TNF-a. may play a role in ischemic tolerance.
